23andMe Holding Co.
General ticker "ME" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $142.0M (TTM average)
23andMe Holding Co. does not follow the US Stock Market performance with the rate: -26.7%.
Estimated limits based on current volatility of 7.5%: low 1.11$, high 1.29$
Factors to consider:
- US accounted for 82.0% of revenue in the fiscal year ended 2024-03-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [5.77$, 17.34$]
- 2025-03-31 to 2026-03-31 estimated range: [5.40$, 15.78$]
Financial Metrics affecting the ME estimates:
- Negative: Non-GAAP EPS, $ of -13.40 <= 0.04
- Negative: Operating cash flow per share per price, % of -39.89 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 2.82 < Industry operating cash flow per share per price (median), % of 3.98
- Positive: 43.26 < Shareholder equity ratio, % of 47.71 <= 63.75
- Positive: Interest expense per share, $ of 0 <= 0
Short-term ME quotes
Long-term ME plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $271.89MM | $299.49MM | $219.64MM |
| Operating Expenses | $526.05MM | $623.50MM | $901.11MM |
| Operating Income | $-254.15MM | $-324.01MM | $-681.47MM |
| Non-Operating Income | $33.18MM | $9.58MM | $14.84MM |
| R&D Expense | $189.38MM | $222.60MM | $205.36MM |
| Income(Loss) | $-220.97MM | $-314.43MM | $-666.63MM |
| Taxes | $-3.48MM | $-2.77MM | $0.07MM |
| Profit(Loss)* | $-217.49MM | $-311.66MM | $-666.70MM |
| Stockholders Equity | $915.66MM | $713.94MM | $188.52MM |
| Inventory | $10.79MM | $10.25MM | $12.46MM |
| Assets | $1,152.07MM | $942.60MM | $395.17MM |
| Operating Cash Flow | $-166.83MM | $-165.39MM | $-164.32MM |
| Capital expenditure | $13.97MM | $11.30MM | $9.66MM |
| Investing Cash Flow | $-108.14MM | $-11.30MM | $-9.63MM |
| Financing Cash Flow | $546.00MM | $9.78MM | $3.58MM |
| Earnings Per Share** | $-9.96 | $-13.81 | $-27.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.